Table 1.

Demographics, neurological, urological and sexual characteristics of patients

No. of subjects	101 (100%)
Multiple sclerosis variants Relapsing remittant* Primary progressive* Secondary progressive*	64 (63.3) 28 (27.7) 9 (9.0)
Age (years)**	41.26 ±11.6
Expanded Disability Status Scale (EDSS) (score)**	3.77 ±2.01
Duration of disease (years)**	11.5 ±7.5
Beck Depression Inventory-II (BDI-II) (score)** BDI-II (0-13)* BDI-II (14-19)* BDI-II (20-29)* BDI-II (30-63)*	18.3 ±14.7 43 (42.5) 21 (20.7) 14 (13.8) 23 (22.7)
International Index of Erectile Function (IIEF) IIEF-15 (score)** IIEF-Erectile Function (score)** IIEF-Intercourse Satisfaction (score)** IIEF-Orgasmic Function (score)** IIEF-Sexual desire (score)** IIEF-Overall Satisfaction (score)**	45 ±18.9 17.5 ±8.5 8.6 ±4.2 6.3 ±3.2 6.6 ±2.4 5.8 ±2.4
Male sexual dysfunction (IIEF-15 <60)*	75 (74.2)
Erectile Dysfunction (IIEF-ED <26)*	75 (74.2)
Testosterone (ng/dL)**	457.74 ±132.95
Diabetes*	9 (8.9)
Duration of lower urinary tract symptoms (LUTS) (years)**	8.24 ±7.58
International Prostate Symptom Score (IPSS) IPSS (score)** IPSS (0–7)* IPSS (8–19)* IPSS (20–35)*	14.46 ±9.1 29 (28.7) 44 (43.5) 28 (27.7)
Urodynamics findings Detrusor overactivity* Detrusor underactivity* Detrusor sphincter dyssynergia* Normal*	43 (42.5) 20 (19.8) 10 (9.9) 28 (27.7)

^*number (%)

^**mean±SD